IBDEI02T ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,770,1,4,0)
 ;;=4^L98.2
 ;;^UTILITY(U,$J,358.3,770,2)
 ;;=^5009575
 ;;^UTILITY(U,$J,358.3,771,0)
 ;;=L53.9^^3^32^38
 ;;^UTILITY(U,$J,358.3,771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,771,1,3,0)
 ;;=3^Erythematous condition, unspecified
 ;;^UTILITY(U,$J,358.3,771,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,771,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,772,0)
 ;;=L40.0^^3^32^131
 ;;^UTILITY(U,$J,358.3,772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,772,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,772,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,772,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,773,0)
 ;;=L40.8^^3^32^130
 ;;^UTILITY(U,$J,358.3,773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,773,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,773,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,773,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,774,0)
 ;;=L40.1^^3^32^46
 ;;^UTILITY(U,$J,358.3,774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,774,1,3,0)
 ;;=3^Generalized pustular psoriasis
 ;;^UTILITY(U,$J,358.3,774,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,774,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,775,0)
 ;;=L40.2^^3^32^2
 ;;^UTILITY(U,$J,358.3,775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,775,1,3,0)
 ;;=3^Acrodermatitis continua
 ;;^UTILITY(U,$J,358.3,775,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,775,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,776,0)
 ;;=L40.3^^3^32^132
 ;;^UTILITY(U,$J,358.3,776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,776,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,776,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,776,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,777,0)
 ;;=L40.4^^3^32^48
 ;;^UTILITY(U,$J,358.3,777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,777,1,3,0)
 ;;=3^Guttate psoriasis
 ;;^UTILITY(U,$J,358.3,777,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,777,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,778,0)
 ;;=L29.0^^3^32^128
 ;;^UTILITY(U,$J,358.3,778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,778,1,3,0)
 ;;=3^Pruritus ani
 ;;^UTILITY(U,$J,358.3,778,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,778,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,779,0)
 ;;=L29.9^^3^32^129
 ;;^UTILITY(U,$J,358.3,779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,779,1,3,0)
 ;;=3^Pruritus, unspecified
 ;;^UTILITY(U,$J,358.3,779,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,779,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,780,0)
 ;;=L84.^^3^32^29
 ;;^UTILITY(U,$J,358.3,780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,780,1,3,0)
 ;;=3^Corns and callosities
 ;;^UTILITY(U,$J,358.3,780,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,780,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,781,0)
 ;;=L85.3^^3^32^152
 ;;^UTILITY(U,$J,358.3,781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,781,1,3,0)
 ;;=3^Xerosis cutis
 ;;^UTILITY(U,$J,358.3,781,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,781,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,782,0)
 ;;=L57.0^^3^32^3
 ;;^UTILITY(U,$J,358.3,782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,782,1,3,0)
 ;;=3^Actinic keratosis
 ;;^UTILITY(U,$J,358.3,782,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,782,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,783,0)
 ;;=L82.0^^3^32^50
 ;;^UTILITY(U,$J,358.3,783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,783,1,3,0)
 ;;=3^Inflamed seborrheic keratosis
 ;;^UTILITY(U,$J,358.3,783,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,783,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,784,0)
 ;;=L82.1^^3^32^139
 ;;^UTILITY(U,$J,358.3,784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,784,1,3,0)
 ;;=3^Seborrheic Keratosis NEC
 ;;^UTILITY(U,$J,358.3,784,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,784,2)
 ;;=^303312
 ;;
 ;;$END ROU IBDEI02T
